Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer

European Journal of Cancer ◽

10.1016/j.ejca.2012.12.006 ◽

2013 ◽

Vol 49 (6) ◽

pp. 1196-1204 ◽

Author(s):

Helena Fohlin ◽

Gizeh Pérez-Tenorio ◽

Tommy Fornander ◽

Lambert Skoog ◽

Bo Nordenskjöld ◽

...

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Long Term Prognosis ◽

Positive Breast Cancer

Download Full-text

Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969556.793525549 ◽

2016 ◽

Author(s):

Daniel Vorobiof

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

Positive Breast Cancer

Download Full-text

Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969556.793480576 ◽

2013 ◽

Author(s):

Nancy Lin ◽

Ines Vaz-Luis

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

Positive Breast Cancer

Download Full-text

Abstract P6-07-12: Akt2 expression is associated with good long-term prognosis in estrogen receptor positive breast cancer

10.1158/0008-5472.sabcs12-p6-07-12 ◽

2012 ◽

Author(s):

H Fohlin ◽

G Pérez-Tenorio ◽

T Fornander ◽

L Skoog ◽

B Nordenskjöld ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Estrogen Receptor Positive ◽

Long Term Prognosis ◽

Positive Breast Cancer

Download Full-text

Faculty Opinions recommendation of Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969556.793472475 ◽

2013 ◽

Author(s):

Tommaso Simoncini

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

Positive Breast Cancer

Download Full-text

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

10.1016/s0140-6736(12)61963-1 ◽

2013 ◽

Vol 381 (9869) ◽

pp. 805-816 ◽

Cited By ~ 1020

Author(s):

Christina Davies ◽

Hongchao Pan ◽

Jon Godwin ◽

Richard Gray ◽

Rodrigo Arriagada ◽

...

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Adjuvant Tamoxifen ◽

Long Term Effects ◽

Positive Breast Cancer

Download Full-text

Evaluating the Long-Term Outcomes for Bone Health for Oestrogen Receptor Positive Breast Cancer with the Use of Aromatase Inhibitors

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2019.09.083 ◽

2019 ◽

Vol 45 (11) ◽

pp. 2215

Author(s):

Bhamini Vadhwana ◽

Caroline Mortimer

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitors ◽

Bone Health ◽

Oestrogen Receptor ◽

Long Term Outcomes ◽

Positive Breast Cancer

Download Full-text

171. The long-term prognosis of sentinel lymph node-positive breast cancer patients without axillary dissection

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2014.08.166 ◽

2014 ◽

Vol 40 (11) ◽

pp. S74

Author(s):

Y. Taguchi ◽

H. Yasojima ◽

H. Masuda ◽

M. Mizutani ◽

N. Masuda ◽

...

Keyword(s):

Breast Cancer ◽

Sentinel Lymph Node ◽

Cancer Patients ◽

Axillary Dissection ◽

Breast Cancer Patients ◽

Lymph Node Positive ◽

Long Term Prognosis ◽

Positive Breast Cancer

Download Full-text

Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials

10.1016/s0140-6736(04)16981-x ◽

2004 ◽

Vol 364 (9437) ◽

pp. 858-868 ◽

Author(s):

Bernard Fisher ◽

Jong-Hyeon Jeong ◽

John Bryant ◽

Stewart Anderson ◽

James Dignam ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trials ◽

Oestrogen Receptor ◽

Randomised Clinical Trials ◽

Node Negative ◽

National Surgical Adjuvant Breast ◽

Bowel Project ◽

Positive Breast Cancer

Download Full-text

A phase III trial to determine the activity and safety of fulvestrant (Faslodex®) in premenopausal women with oestrogen-receptor positive breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80305-7 ◽

2002 ◽

Vol 38 (11) ◽

pp. S97 ◽

Author(s):

J Robertson

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Premenopausal Women ◽

Phase Iii ◽

Phase Iii Trial ◽

Positive Breast Cancer

Download Full-text

E14. The prognostic and predictive value of the progesterone receptor in women with an oestrogen receptor-positive breast cancer

European Journal of Cancer Supplements ◽

10.1016/j.ejcsup.2004.08.013 ◽

2004 ◽

Vol 2 (9) ◽

pp. 46-48 ◽

Keyword(s):

Breast Cancer ◽

Progesterone Receptor ◽

Predictive Value ◽

Oestrogen Receptor ◽

Positive Breast Cancer

Download Full-text